Thiopropazate
Thiopropazate is a typical antipsychotic of the phenothiazine class. It was introduced in the 1960s by Rhône-Poulenc and is used in Europe, including Austria, Belgium, Czech Republic, France, and Slovakia. Thiopropazate has similar effects to other typical antipsychotics, and is used for the treatment of schizophrenia and other types of psychosis.
Pharmacology[edit | edit source]
Thiopropazate is a D2 receptor antagonist. It works by blocking the action of dopamine, a neurotransmitter in the brain that is involved in mood and behavior. This can help to reduce symptoms of psychosis, such as hallucinations, delusions, and disorganized thinking.
Side effects[edit | edit source]
Like other typical antipsychotics, thiopropazate can cause a range of side effects. These can include drowsiness, dizziness, dry mouth, constipation, and blurred vision. More serious side effects can include tardive dyskinesia, a condition characterized by involuntary movements, and neuroleptic malignant syndrome, a rare but potentially life-threatening reaction to antipsychotic drugs.
See also[edit | edit source]
Thiopropazate Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD